Динаміка рН при хворобі Крона: наслідки для мікробіоти кишечника та терапевтичні стратегії

Автор(и)

  • Р. Сілва Медична клініка доктора Річарда, С. Жуан да Мадейра, Авейру, Португалія
  • Х. Азеведо Медичні технології та послуги, Мірандела, Португалія https://orcid.org/0000-0002-9270-5563
  • Х. Мачадо Школа медицини та біомедичних наук, Університет Порту; Центр біологічних наук в інтегративній охороні здоров’я, Порту, Португалія https://orcid.org/0000-0003-4570-5445
  • Х. Родрігес Школа медицини та біомедичних наук, Університет Порту; Центр біологічних наук в інтегративній охороні здоров’я, Порту, Португалія https://orcid.org/0000-0001-5892-1855

DOI:

https://doi.org/10.30978/MG-2025-1-87

Ключові слова:

pH, кишкова мікробіота, хвороба Крона, запальні захворювання кишечника

Анотація

Хвороба Крона (ХК) — це хронічне запальне захворювання кишечника, що характеризується запаленням, яке може вражати весь кишечник, причому частою мішенню є дистальний відділ клубової кишки. Незважаючи на значний прогрес у лікуванні ХК, залишаються незадоволені медичні потреби, що зумовлює необхідність розробки нових та цільових підходів. Сучасні дослідження пролили світло на складний патогенез ХК, що включає різні фактори, зокрема вплив навколишнього середовища, взаємодію імунної системи, генетичну схильність та зміни в мікробіомі кишечника. Серед цих факторів рН, який відіграє вирішальну роль у здоров’ї кишечника, став ключовим показником, що впливає на структуру та функціонування мікробних спільнот. У пацієнтів із ХК спостерігаються зміни рН‑профілю, особливо в товстому кишечнику, що потенційно може впливати на склад і функцію мікробіоти кишечника. Крім того, рН є життєво важливим для підтримки цілісності слизової оболонки кишечника та оптимізації доставки ліків. З огляду на ці результати, цілеспрямована модуляція рН є перспективним додатковим підходом до чинних методів лікування ХК. Точне регулювання рівня рН може сприяти створенню середовища, яке підтримує корисні бактерії, зміцнює кишковий бар’єр і підвищує ефективність ліків. Однак необхідні подальші дослідження для повного розуміння складних взаємодій між мікробіотою кишечника, рН та імунною системою господаря заради безпеки й потенційних наслідків модуляції рН. Пошук нових ефективних методів лікування, включаючи модуляцію рН, обіцяє покращити якість життя людей, які живуть з ХК, що вимагає продовження досліджень та клінічних випробувань для вивчення їхньої доцільності й переваг у лікуванні ХК.

 

Посилання

Aamodt G, Bukholm G, Jahnsen J, Moum B, Vatn MH. The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway. Am J Epidemiol. 2008;168(9):1065-72. Epub 2008/09/20. http://doi.org/10.1093/aje/kwn218. PMID: 18801890.

Abbott FV, Hong Y, Blier P. Activation of 5-HT2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology. 1996;35(1):99-110. https://doi.org/10.1016/0028-3908(95)00136-0.

Alrubia S, Mao J, Chen Y, Barber J, Rostami-Hodjegan A. Altered bioavailability and pharmacokinetics in Crohn’s disease: capturing systems parameters for PBPK to assist with predicting the fate of orally administered drugs. Clin Pharmacokinet. 2022;61(10):1365-92. Epub 2022/09/03. http://doi.org/10.1007/s40262-022-01169-4.

Aoi W, Marunaka Y. Importance of pH homeostasis in metabolic health and diseases: crucial role of membrane proton transport. Biomed Res Int. 2014;2014:598986. Epub 2014/10/11. http://doi.org/10.1155/2014/598986. PMID: 25302301; PMCID: PMCPMC4180894.

Appleton J. The gut-brain axis: influence of microbiota on mood and mental health. Integr Med (Encinitas). 2018;17(4):28-32. Epub 2019/05/03. PMID: 31043907; PMCID: PMCPMC6469458.

Ballan R, Battistini C, Xavier-Santos D, Saad SMI. Chapter Nine. Interactions of probiotics and prebiotics with the gut microbiota. In: Sun J, editor. Progress in Molecular Biology and Translational Science. 171: Academic Press; 2020. P. 265-300.

Belenguer A, Duncan SH, Holtrop G, Anderson SE, Lobley GE, Flint HJ. Impact of pH on lactate formation and utilization by human fecal microbial communities. Appl Environ Microbiol. 2007;73(20):6526-33. Epub 2007/09/04. http://doi.org/10.1128/AEM.00508-07. PMID: 17766450; PMCID: PMCPMC2075063.

Beloqui A, Coco R, Memvanga PB, Ucakar B, des Rieux A, Preat V. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease. Int J Pharm. 2014;473(1-2):203-12. Epub 2014/07/12. http://doi.org/10.1016/j.ijpharm.2014.07.009. PMID: 25014369.

Berthold-Pluta A, Pluta A, Garbowska M. The effect of selected factors on the survival of Bacillus cereus in the human gastrointestinal tract. Microb Pathog. 2015;82:7-14. Epub 2015/03/22. http://doi.org/10.1016/j.micpath.2015.03.015.

Bibbo S, Ianiro G, Giorgio V, et al. The role of diet on gut microbiota composition. Eur Rev Med Pharmacol Sci. 2016;20(22):4742-9. Epub 2016/12/03. PMID: 27906427.

Bongers A, van den Heuvel EG. Prebiotics and the bioavailability of minerals and trace elements. Food Reviews International. 2003;19(4):397-422. http://doi.org/10.1081/FRI-120025482.

Bown R, Gibson J, Sladen G, Hicks B, Dawson A. Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device. Gut. 1974;15(12):999-1004.

Brinkman JE, Sharma S. Respiratory Alkalosis. StatPearls: StatPearls Publishing; 2023.

Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28(2):203-9. Epub 2015/04/02. PMID: 25830558; PMCID: PMCPMC4367209.

Chung Y-C, Hsu C-K, Ko C-Y, Chan Y-C. Dietary intake of xylooligosaccharides improves the intestinal microbiota, fecal moisture, and pH value in the elderly. Nutrition Research. 2007;27(12):756-61. https://doi.org/10.1016/j.nutres.2007.09.014.

Coates MD, Tekin I, Vrana KE, Mawe GM. Review article: the many potential roles of intestinal serotonin (5-hydroxytryptamine, 5-HT) signalling in inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46(6):569-80. Epub 2017/07/25. http://doi.org/10.1111/apt.14226. PMID: 28737264.

Collins SM, Kassam Z, Bercik P. The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol. 2013;16(3):240-5. Epub 2013/07/13. http://doi.org/10.1016/j.mib.2013.06.004. PMID: 23845749.

Crohn BB. Regional Ileitis. Journal of the American Medical Association. 1932;99(16):1323-9. http://doi.org/10.1001/jama.1932.02740680019005.

Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701-12. http://doi.org/10.1038/nrn3346.

Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev. 2004 Jul;3(5):394-400. http://doi.org/10.1016/j.autrev.2004.03.002.

Duar RM, Henrick BM, Casaburi G, Frese SA. Integrating the ecosystem services framework to define dysbiosis of the breastfed infant gut: the role of B. infantis and human milk oligosaccharides. Front Nutr. 2020 Apr 14;7:33. http://doi.org/10.3389/fnut.2020.00033.

Duar RM, Kyle D, Casaburi G. Colonization Resistance in the Infant Gut: The Role of B. infantis in Reducing pH and Preventing Pathogen Growth. High Throughput. 2020 Mar 27;9(2):7. http://doi.org/10.3390/ht9020007. PMCID: PMC7349288.

Duncan SH, Louis P, Thomson JM, Flint HJ. The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol. 2009;11(8):2112-22. Epub 2009/04/29. http://doi.org/10.1111/j.1462-2920.2009.01931.x.

Duncan SH, Scott KP, Ramsay AG, Harmsen HJ, Welling GW, Stewart CS, Flint HJ. Effects of alternative dietary substrates on competition between human colonic bacteria in an anaerobic fermentor system. Appl Environ Microbiol. 2003 Feb;69(2):1136-42. http://doi.org/10.1128/AEM.69.2.1136-1142.2003.

Dzierba AL, Abraham P. A practical approach to understanding acid-base abnormalities in critical illness. J Pharm Pract. 2011;24(1):17-26. http://doi.org/10.1177/0897190010388153.

Edwards SL. Pathophysiology of acid base balance: the theory practice relationship. Intensive Crit Care Nurs. 2008;24(1):28-38; quiz -40. Epub 2007/08/11. http://doi.org/10.1016/j.iccn.2007.05.003.

Elman I, Pustilnik A, Borsook D. Beating pain with psychedelics: Matter over mind? Neurosci Biobehav Rev. 2022;134:104482. https://doi.org/10.1016/j.neubiorev.2021.12.005.

Evans DF, Pye G, Bramley R, et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut. 1988;29(8):1035-41. http://doi.org/10.1136/gut.29.8.1035.

Fallingborg J, Pedersen P, Jacobsen BA. Small intestinal transit time and intraluminal pH in ileocecal resected patients with Crohn’s disease. Dig Dis Sci. 1998;43(4):702-5. Epub 1998/04/29. http://doi.org/10.1023/a:1018893409596. PMID: 9558022.

Fallingborg J. Intraluminal pH of the human gastrointestinal tract. Dan Med Bull. 1999 Jun;46(3):183-96. PMID: 10421978.

Farmer AD, Randall HA, Aziz Q. It’s a gut feeling: How the gut microbiota affects the state of mind. The Journal of Physiology. 2014;592(14):2981-8. http://doi.org/10.1113/jphysiol.2013.270389.

Fawley J, Gourlay DM. Intestinal alkaline phosphatase: a summary of its role in clinical disease. J Surg Res. 2016;202(1):225-34. Epub 2016/04/17. http://doi.org/10.1016/j.jss.2015.12.008.

Feng J, Wang Y, Lv Y, et al. XA pH-responsive and colitis-targeted nanoparticle loaded with shikonin for the oral treatment of inflammatory bowel disease in mice. Mol Pharm. 2022;19(11):4157-70. Epub 2022/09/16. http://doi.org/10.1021/acs.molpharmaceut.2c00550. PMID: 36106774.

Fiorani M, Tohumcu E, Del Vecchio LE, et al. The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota. Antibiotics (Basel). 2023;12(4). Epub 2023/04/28. http://doi.org/10.3390/antibiotics12040765. PMCID: PMCPMC10135037.

Fiorica-Howells E, Hen R, Gingrich J, Li Z, Gershon MD. 5-HT(2A) receptors: location and functional analysis in intestines of wild-type and 5-HT(2A) knockout mice. Am J Physiol Gastrointest Liver Physiol. 2002;282(5):G877-93. Epub 2002/04/19. http://doi.org/10.1152/ajpgi.00435.2001. PMID: 11960784.

Firrman J, Liu L, Mahalak K, et al. The impact of environmental pH on the gut microbiota community structure and short chain fatty acid production. FEMS Microbiol Ecol. 2022;98(5):fiac038. http://doi.org/10.1093/femsec/fiac038.

Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305-12. Epub 2013/02/07. http://doi.org/10.1016/j.tins.2013.01.005. PMID: 23384445.

Golovics PA, Mandel MD, Lovasz BD, Lakatos PL. Inflammatory bowel disease course in Crohn’s disease: is the natural history changing? World Journal of Gastroenterology. 2014;20(12):3198-207. Epub 2014/04/04. http://doi.org/10.3748/wjg.v20.i12.3198. PMID: 24696605; PMCID: PMCPMC3964392.

Gross V, Andus T, Caesar I, et al. Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn’s disease. German/Austrian Budesonide Study Group. Eur J Gastroenterol Hepatol. 1996;8(9):905-9. Epub 1996/09/01.

Gross V, Andus T, Ecker KW, et al. Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease. The Budesonide Study Group. Gut. 1998;42(4):493-6. Epub 1998/06/09. http://doi.org/10.1136/gut.42.4.493.

Harrison RA. Acid-base balance. Respir Care Clin N Am. 1995;1(1):7-21. Epub 1995/09/01. PMID: 9390847.

Hoarau G, Mukherjee PK, Gower-Rousseau C, et al. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease. mBio. 2016 Sep 20;7(5):e01250-16. http://doi.org/10.1128/mBio.01250-16.

Hopkins E, Sanvictores T, Sharma S. Physiology, Acid Base Balance. StatPearls: StatPearls Publishing; 2023.

Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563-73. Epub 2011/04/07. http://doi.org/10.1038/ajg.2011.44. PMID: 21468064.

Ilhan ZE, Marcus AK, Kang DW, Rittmann BE, Krajmalnik-Brown R. pH-Mediated microbial and metabolic interactions in fecal enrichment cultures. mSphere. 2017;2(3). Epub 2017/05/13. http://doi.org/10.1128/mSphere.00047-17.

Iwanami K, Takeyoshi I, Ohwada S, et al. Intramucosal pH and intestinal mucosal damage in ischemia-reperfusion injury. Transplant International. 1998;11(6):401-7. http://doi.org/10.1111/j.1432-2277.1998.tb00827.x.

Jäger A, Kuchroo VK. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol. 2010 Sep;72(3):173-84. http://doi.org/10.1111/j.1365-3083.2010.02432.x.

Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World journal of gastroenterology. 2015;21(29):8787-803. Epub 2015/08/14. http://doi.org/10.3748/wjg.v21.i29.8787.

Jensen SK, Pærregaard SI, Brandum EP, Jørgensen AS, Hjortø GM, Jensen BAH. Rewiring host-microbe interactions and barrier function during gastrointestinal inflammation. Gastroenterol Rep (Oxf). 2022 Mar 11;10(1):goac008. http://doi.org/10.1093/gastro/goac008. PMID: 35291443; PMCID: PMC8915887.

Jensen WB. The symbol for pH. Journal of Chemical Education. 2004;81(1):21. http://doi.org/10.1021/ed081p21.

Jin Q, Kirk MF. pH as a primary control in environmental microbiology: 1. thermodynamic perspective. Frontiers in Environmental Science. 2018;6:21. http://doi.org/10.3389/fenvs.2018.00021.

Kamada N, Chen GY, Inohara N, Nunez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. 2013;14(7):685-90. Epub 2013/06/20. http://doi.org/10.1038/ni.2608. PMID: 23778796; PMCID: PMCPMC4083503.

Kaplan GG, Hubbard J, Korzenik J, et al. The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol. 2010;105(11):2412-9. Epub 2010/07/01. http://doi.org/10.1038/ajg.2010.252. PMCID: PMCPMC3180712.

Kennedy PJ, Clarke G, Quigley EM, Groeger JA, Dinan TG, Cryan JF. Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev. 2012;36(1):310-40. Epub 2011/07/23. http://doi.org/10.1016/j.neubiorev.2011.07.001. PMID: 21777613.

Kloetzer L, Gaman A, Nojkov B, et al. Complete pH profiling of the gastrointestinal tract in healthy volunteers with an ambulatory pH capsule. Gastroenterology. 2007;132.

Klymiuk I, Bilgilier C, Stadlmann A, et al. The human gastric microbiome is predicated upon infection with Helicobacter pylori. Front Microbiol. 2017;8:2508. Epub 2018/01/10. http://doi.org/10.3389/fmicb.2017.02508. PMCID: PMCPMC5735373.

Konig J, Wells J, Cani PD, et al. Human intestinal barrier function in health and disease. Clin Transl Gastroenterol. 2016;7(10):e196. Epub 2016/10/21. http://doi.org/10.1038/ctg.2016.54. PMID: 27763627; PMCID: PMCPMC5288588.

Kumar A, Cole A, Segal J, Smith P, Limdi JK. A review of the therapeutic management of Crohn’s disease. Therap Adv Gastroenterol. 2022;15:17562848221078456. Epub 2022/02/25. http://doi.org/10.1177/17562848221078456.

Lauber CL, Hamady M, Knight R, Fierer N. Pyrosequencing-based assessment of soil pH as a predictor of soil bacterial community structure at the continental scale. Appl Environ Microbiol. 2009 Aug;75(15):5111-20. http://doi.org/10.1128/AEM.00335-09.

Lyte M. Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathog. 2013;9(11):e1003726. Epub 2013/11/19. http://doi.org/10.1371/journal.ppat.1003726. PMID: 24244158; PMCID: PMCPMC3828163.

Macfarlane GT, Gibson GR, Cummings JH. Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol. 1992;72(1):57-64. Epub 1992/01/01. http://doi.org/10.1111/j.1365-2672.1992.tb04882.x. PMID: 1541601.

Mai J, Wang H, Yang XF. Th17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity. Front Biosci (Landmark Ed). 2010 Jun 1;15(3):986-1006. http://doi.org/10.2741/3657. PMID: 20515737; PMCID: PMC2880832.

Markoutsaki T, Karantanos T, Gazouli M, Anagnou NP, Karamanolis DG. 5-HT2A receptor gene polymorphisms and irritable bowel syndrome. J Clin Gastroenterol. 2011 Jul;45(6):514-7. http://doi.org/10.1097/MCG.0b013e318205e13b. PMID: 21325954.

Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology. 2014;146(6):1500-12. Epub 2014/03/04. http://doi.org/10.1053/j.gastro.2014.02.037. PMID: 24583088; PMCID: PMCPMC4114504.

Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12(8):453-66. Epub 2011/07/14. http://doi.org/10.1038/nrn3071. PMCID: PMCPMC3845678.

Mikolajczyk AE, Watson S, Surma BL, Rubin DT. Assessment of Tandem Measurements of pH and Total Gut Transit Time in Healthy Volunteers. Clin Transl Gastroenterol. 2015 Jul 9;6(7):e100. http://doi.org/10.1038/ctg.2015.22. PMCID: PMC4816255.

Moloney RD, Desbonnet L, Clarke G, et al. The microbiome: stress, health and disease. Mamm Genome. 2014;25(1-2):49-74. Epub 2013/11/28. http://doi.org/10.1007/s00335-013-9488-5.

Naser SA, Arce M, Khaja A, Fernandez M, Naser N, Elwasila S, Thanigachalam S. Role of ATG16L, NOD2 and IL23R in Crohn’s disease pathogenesis. World J Gastroenterol. 2012 Feb 7;18(5):412-24. http://doi.org/10.3748/wjg.v18.i5.412.

Nasser KK, Shinawi T. Genotype-protein phenotype characterization of NOD2 and IL23R missense variants associated with inflammatory bowel disease: A paradigm from molecular modelling, dynamics, and docking simulations. Front Med (Lausanne). 2023 Jan 10;9:1090120. http://doi.org/10.3389/fmed.2022.1090120. PMID: 36703890; PMCID: PMC9871552.

Newton A, Kumar N. IBD–impact of colonic pH, onset of action and other factors in modern therapeutic approach. Interdiscip J Microinflammation. 2014;1(116):2.

Nugent SG, Kumar D, Rampton DS, Evans DF. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut. 2001;48(4):571-7. Epub 2001/03/15. http://doi.org/10.1136/gut.48.4.571. PMID: 11247905; PMCID: PMCPMC1728243.

Oldner A, Wanecek M, Goiny M, et al. The endothelin receptor antagonist bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock. Gut. 1998;42(5):696-702. Epub 1998/07/11. http://doi.org/10.1136/gut.42.5.696. PMID: 9659167; PMCID: PMCPMC1727119.

Petagna L, Antonelli A, Ganini C, et al. Pathophysiology of Crohn’s disease inflammation and recurrence. Biol Direct. 2020;15(1):23. Epub 2020/11/09. http://doi.org/10.1186/s13062-020-00280-5. PMID: 33160400; PMCID: PMCPMC7648997.

Raote I, Bhattacharya A, Panicker M. Serotonin 2A (5-HT2A) Receptor Function: Ligand-Dependent Mechanisms and Pathways. In: Chattopadhyay A, editor. Serotonin Receptors in Neurobiology: Frontiers in Neuroscience; 2007.

Rashed R, Valcheva R, Dieleman LA. Manipulation of gut microbiota as a key target for Crohn’s disease. Frontiers in medicine. 2022;9:887044. Epub 2022/07/06. http://doi.org/10.3389/fmed.2022.887044. PMCID: PMCPMC9244564.

Ratzke C, Gore J. Modifying and reacting to the environmental pH can drive bacterial interactions. PLoS Biol. 2018;16(3):e2004248. Epub 2018/03/15. http://doi.org/10.1371/journal.pbio.2004248.

Reider S, Binder L, Fürst S, Hatzl S, Blesl A. Hematopoietic Stem Cell Transplantation in Refractory Crohn’s Disease: Should It Be Considered? Cells. 2022 Nov 2;11(21):3463. http://doi.org/10.3390/cells11213463. PMID: 36359859; PMCID: PMC9656531.

Reznikov EA, Suskind DL. Current Nutritional Therapies in Inflammatory Bowel Disease: Improving Clinical Remission Rates and Sustainability of Long-Term Dietary Therapies. Nutrients. 2023 Jan 28;15(3):668. http://doi.org/10.3390/nu15030668.

Sasaki Y, Hada R, Nakajima H, Fukuda S, Munakata A. Improved localizing method of radiopill in measurement of entire gastrointestinal pH profiles: colonic luminal pH in normal subjects and patients with Crohn’s disease. Am J Gastroenterol. 1997;92(1):114-8. Epub 1997/01/01. PMID: 8995949.

Scott KP, Duncan SH, Flint HJ. Dietary fibre and the gut microbiota. Nutrition Bulletin. 2008;33(3):201-11. http://doi.org/10.1111/j.1467-3010.2008.00706.x.

Seksik P, Nion-Larmurier I, Sokol H, Beaugerie L, Cosnes J. Effects of light smoking consumption on the clinical course of Crohn’s disease. Inflamm Bowel Dis. 2009;15(5):734-41. Epub 2008/12/11. http://doi.org/10.1002/ibd.20828. PMID: 19067428.

Shajib MS, Baranov A, Khan WI. Diverse effects of gut-derived serotonin in intestinal inflammation. ACS Chem Neurosci. 2017;8(5):920-31. Epub 2017/03/16. http://doi.org/10.1021/acschemneuro.6b00414. PMID: 28288510.

Sherman MP, Zaghouani H, Niklas V. Gut microbiota, the immune system, and diet influence the neonatal gut-brain axis. Pediatr Res. 2015;77(1-2):127-35. Epub 2014/10/11. http://doi.org/10.1038/pr.2014.161. PMID: 25303278.

Stingl K, Uhlemann Em EM, Deckers-Hebestreit G, Schmid R, Bakker EP, Altendorf K. Prolonged survival and cytoplasmic pH homeostasis of Helicobacter pylori at pH 1. Infect Immun. 2001;69(2):1178-80. Epub 2001/02/13. http://doi.org/10.1128/IAI.69.2.1178-1181.2001. PMCID: PMCPMC98001.

Tuvlin JA, Raza SS, Bracamonte S, et al. Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts. Inflamm Bowel Dis. 2007;13(5):573-9. http://doi.org/10.1002/ibd.20043.

Vitzthum H, Koch M, Eckermann L, et al. The AE4 transporter mediates kidney acid-base sensing. Nat Commun. 2023;14(1):3051. Epub 2023/05/27. http://doi.org/10.1038/s41467-023-38562-x. PMID: 37236964; PMCID: PMCPMC10220024.

Walker AW, Duncan SH, McWilliam Leitch EC, et al. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol. 2005;71(7):3692-700. Epub 2005/07/08. http://doi.org/10.1128/AEM.71.7.3692-3700.2005.

Watson BW, Meldrum SJ, Riddle HC, et al. pH profile of gut as measured by radiotelemetry capsule. Br Med J. 1972;2(5805):104-6. Epub 1972/04/08. http://doi.org/10.1136/bmj.2.5805.104.

Zeeshan M, Ali H, Khan S, Khan SA, Weigmann B. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. Int J Pharm. 2019;558:201-14. Epub 2019/01/08. http://doi.org/10.1016/j.ijpharm.2018.12.074. PMID: 30615925.

Zhang G, Stackman RW. The role of serotonin 5-HT2A receptors in memory and cognition. Front Pharmacol. 2015;6. http://doi.org/10.3389/fphar.2015.00225.

Zhang J, Chen Z, Kong J, et al. Fullerenol nanoparticles eradicate Helicobacter pylori via pH-responsive peroxidase activity. ACS Appl Mater Interfaces. 2020;12(26). Epub 2020/06/04. http://doi.org/10.1021/acsami.0c05509. PMID: 32486636.

Zoetendal EG, Akkermans AD, de Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol. 1998;64(10):3854-9. Epub 1998/10/06. http://doi.org/10.1128/AEM.64.10.3854-3859.1998.

Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol. 2002;68(7):3401-7. Epub 2002/06/29. http://doi.org/10.1128/AEM.68.7.3401-3407.2002.

##submission.downloads##

Опубліковано

2025-03-26

Номер

Розділ

Огляди